Joanna Peng

614 total citations
14 papers, 404 citations indexed

About

Joanna Peng is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Joanna Peng has authored 14 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 2 papers in Molecular Biology. Recurrent topics in Joanna Peng's work include CAR-T cell therapy research (2 papers), Adipose Tissue and Metabolism (2 papers) and Diabetes Treatment and Management (2 papers). Joanna Peng is often cited by papers focused on CAR-T cell therapy research (2 papers), Adipose Tissue and Metabolism (2 papers) and Diabetes Treatment and Management (2 papers). Joanna Peng collaborates with scholars based in United States, Australia and Japan. Joanna Peng's co-authors include Corby K. Martin, Wei Shen, Allison Martin Nguyen, S. B. Heymsfield, Diana M. Thomas, Manfred J. Müller, Anja Bosy‐Westphal, Boyd J. Strauss, Rory P. Remmel and Ronald J. Sawchuk and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Joanna Peng

14 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanna Peng United States	12	88	87	86	77	65	14	404
Benedetta Chiodini Belgium	11	100 1.1×	62 0.7×	52 0.6×	75 1.0×	117 1.8×	20	449
Todd Fairhead Canada	11	104 1.2×	170 2.0×	129 1.5×	67 0.9×	74 1.1×	19	630
Adnan Khosravi Iran	11	135 1.5×	98 1.1×	51 0.6×	120 1.6×	56 0.9×	51	454
Ismael Dale Cotrim Guerreiro da Silva Brazil	18	40 0.5×	127 1.5×	42 0.5×	185 2.4×	90 1.4×	53	668
Agnieszka Bińczak‐Kuleta Poland	14	45 0.5×	55 0.6×	39 0.5×	119 1.5×	74 1.1×	44	392
Dominika Szőke Italy	11	51 0.6×	93 1.1×	74 0.9×	94 1.2×	141 2.2×	33	428
Myoung Ju Koh South Korea	9	58 0.7×	89 1.0×	36 0.4×	78 1.0×	59 0.9×	14	412
Xiaona Chang China	12	110 1.3×	37 0.4×	39 0.5×	149 1.9×	37 0.6×	47	438
Wipawee Kittikowit Thailand	10	25 0.3×	84 1.0×	106 1.2×	105 1.4×	54 0.8×	16	447
Chaoyang Chen China	13	63 0.7×	28 0.3×	66 0.8×	78 1.0×	28 0.4×	41	397

Countries citing papers authored by Joanna Peng

Since Specialization

Citations

This map shows the geographic impact of Joanna Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Peng more than expected).

Fields of papers citing papers by Joanna Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Peng. The network helps show where Joanna Peng may publish in the future.

Co-authorship network of co-authors of Joanna Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Peng. A scholar is included among the top collaborators of Joanna Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Peng. Joanna Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hong, David S., Michael A. Postow, Bartosz Chmielowski, et al.. (2023). Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial. Clinical Cancer Research. 29(12). 2210–2219. 48 indexed citations

Kiyooka, Takahiko, Vahagn Ohanyan, Liya Yin, et al.. (2022). Mitochondrial DNA integrity and function are critical for endothelium-dependent vasodilation in rats with metabolic syndrome. Basic Research in Cardiology. 117(1). 3–3. 13 indexed citations

Berger, Zdenek, Eugenio Mercuri, Janbernd Kirschner, et al.. (2021). Population pharmacokinetics-based recommendations for a single delayed or missed dose of nusinersen. Neuromuscular Disorders. 31(4). 310–318. 15 indexed citations

Peng, Joanna, et al.. (2021). Occipital Neuralgia. Current Pain and Headache Reports. 25(9). 61–61. 9 indexed citations

Sullivan, Barbara, Wayne Tsuji, Alan Kivitz, et al.. (2016). Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus. Lupus Science & Medicine. 3(1). e000146–e000146. 58 indexed citations

Yang, Bing, Mélanie Dieudé, Katia Hamelin, et al.. (2016). Anti-LG3 Antibodies Aggravate Renal Ischemia–Reperfusion Injury and Long-Term Renal Allograft Dysfunction. American Journal of Transplantation. 16(12). 3416–3429. 38 indexed citations

Krishna, Rajesh, Carol Addy, Daniel Tatosian, et al.. (2016). Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once‐Weekly Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitor, After Single and Multiple Doses in Healthy Subjects. The Journal of Clinical Pharmacology. 56(12). 1528–1537. 29 indexed citations

Alvarez‐Núñez, Fernando, Vincent Chow, Dominick Daurio, et al.. (2015). Utilizing Physiologically Based Pharmacokinetic Modeling to Inform Formulation and Clinical Development for a Compound with pH-Dependent Solubility. Journal of Pharmaceutical Sciences. 104(4). 1522–1532. 14 indexed citations

Moskowitz, Craig H., Michelle A. Fanale, Bijal Shah, et al.. (2015). A Phase 1 Study of Denintuzumab Mafodotin (SGN-CD19A) in Relapsed/Refactory B-Lineage Non-Hodgkin Lymphoma. Blood. 126(23). 182–182. 35 indexed citations

10.

Peng, Joanna, William S. Denney, Bret J. Musser, et al.. (2014). A Semi-mechanistic Model for the Effects of a Novel Glucagon Receptor Antagonist on Glucagon and the Interaction Between Glucose, Glucagon, and Insulin Applied to Adaptive Phase II Design. The AAPS Journal. 16(6). 1259–1270. 15 indexed citations

11.

Peng, Joanna, David E. Gutstein, Lisa A. Beck, et al.. (2012). Quantifying Monocyte Infiltration in Response to Intradermal Tetanus Toxoid Injection. Biomarkers in Medicine. 6(4). 541–551. 1 indexed citations

12.

Heymsfield, S. B., Diana M. Thomas, Allison Martin Nguyen, et al.. (2010). Voluntary weight loss: systematic review of early phase body composition changes. Obesity Reviews. 12(5). e348–61. 77 indexed citations

13.

Peng, Joanna, Federico Pulido, Jianling Li, et al.. (2006). Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus–Coinfected Subjects With Hepatic Impairment. The Journal of Clinical Pharmacology. 46(3). 265–274. 34 indexed citations

14.

Peng, Joanna, Rory P. Remmel, & Ronald J. Sawchuk. (2004). INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES. Drug Metabolism and Disposition. 32(8). 805–812. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact